Amylyx Pharmaceuticals In... (AMLX)
NASDAQ: AMLX
· Real-Time Price · USD
8.01
-0.40 (-4.76%)
At close: Aug 15, 2025, 3:59 PM
8.08
0.87%
After-hours: Aug 15, 2025, 06:49 PM EDT
Amylyx Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.45 | -2.11 | -1.73 | -0.76 | -0.44 | -0.39 | 52.44 | 14.77 | 16.42 | 311.11 | -14.15 | -7.66 | -5.18 | -3.45 | -8.8 | -10.78 | -9.47 | -14.29 |
PEG Ratio | -0.32 | 0.09 | 0.04 | n/a | 0.01 | 0.00 | -0.68 | -2.44 | 0.01 | -3 | 0.48 | 7.13 | n/a | -0.04 | -0.41 | 0.86 | -0.19 | -0.21 |
PS Ratio | n/a | n/a | -389.9 | 530.33 | -125.01 | 2.07 | 9.15 | 12.02 | 14.77 | 27.41 | 110.45 | 4.78K | n/a | n/a | n/a | 3.5K | n/a | n/a |
PB Ratio | 3.40 | 1.51 | 1.57 | 1.12 | 0.49 | 0.57 | 2.29 | 2.95 | 3.75 | 5.55 | 7.10 | 11.44 | 5.81 | 2.74 | -6.6 | -8.04 | n/a | 155.58 |
P/FCF Ratio | -22.62 | -7.62 | -4.39 | -5.31 | -1.92 | -330.73 | 75.21 | -223.37 | 174.08 | -367.81 | -48.04 | -37.85 | -23.54 | -16.13 | -35.1 | -47.47 | -63.64 | -65.6 |
P/OCF Ratio | -22.63 | -7.62 | -4.39 | -5.31 | -1.92 | -376.04 | 73.23 | -238.8 | 168.46 | -385.94 | -48.64 | -38.25 | -24.1 | -16.27 | -35.33 | -47.82 | -63.64 | -65.68 |
OCF/S Ratio | n/a | n/a | 88.73 | -99.93 | 65.08 | -0.01 | 0.12 | -0.05 | 0.09 | -0.07 | -2.27 | -124.86 | n/a | n/a | n/a | -73.21 | n/a | n/a |
Debt / Equity Ratio | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.05 | 0.04 | 0.03 | n/a | -0.00 | n/a | n/a |
Quick Ratio | 8.72 | 12.05 | 6.67 | 4.55 | 4.66 | 4.48 | 5.20 | 8.81 | 6.28 | 7.59 | 7.99 | 5.24 | 7.96 | 9.58 | 5.84 | 8.58 | n/a | n/a |
Current Ratio | 8.72 | 12.05 | 6.67 | 4.55 | 4.66 | 4.48 | 5.66 | 9.52 | 6.67 | 7.86 | 8.20 | 5.26 | 7.96 | 9.58 | 5.84 | 8.58 | n/a | n/a |
Asset Turnover | n/a | n/a | -0.00 | 0.00 | -0.00 | 0.21 | 0.21 | 0.22 | 0.22 | 0.18 | 0.06 | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.64K | n/a | n/a |
Return on Equity | -0.25 | -0.18 | -0.23 | -0.37 | -0.28 | -0.37 | 0.01 | 0.05 | 0.06 | n/a | -0.13 | -0.37 | -0.28 | -0.2 | 0.19 | 0.19 | n/a | -2.72 |
Return on Assets | -0.21 | -0.16 | -0.19 | -0.29 | -0.22 | -0.28 | 0.01 | 0.04 | 0.05 | n/a | -0.11 | -0.3 | -0.24 | -0.17 | -0.27 | -0.18 | n/a | n/a |
Return on Invested Capital | -0.25 | -0.19 | -0.24 | -0.38 | -0.2 | -0.37 | n/a | 0.04 | 0.05 | -0.01 | -0.13 | -0.36 | -0.27 | -0.19 | -0.32 | -0.2 | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 1.24 | -0.94 | 8.45 | -0.32 | 0.91 | 0.95 | 0.94 | 0.93 | 0.87 | 0.50 | n/a | n/a | n/a | -44.1 | n/a | n/a |
Net Profit Margin | n/a | n/a | 56.46 | -174.77 | 71.07 | -1.34 | 0.04 | 0.20 | 0.22 | 0.02 | -1.95 | -155.81 | n/a | n/a | n/a | -81.2 | n/a | n/a |
Pretax Profit Margin | n/a | n/a | 57.42 | -174.77 | 71.07 | -1.34 | 0.06 | 0.22 | 0.24 | 0.02 | -1.92 | -156.18 | n/a | n/a | n/a | -81.2 | n/a | n/a |
Operating Profit Margin | n/a | n/a | 61.13 | -181.88 | 52.23 | -1.38 | 0.02 | 0.18 | 0.21 | -0.03 | -2.04 | -158.5 | n/a | n/a | n/a | -80.41 | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | 60.89 | -181.35 | 52.03 | -1.37 | 0.02 | 0.19 | 0.21 | -0.03 | -2.03 | -158.02 | n/a | n/a | n/a | -80.38 | n/a | n/a |